Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area - PubMed (original) (raw)
Comparative Study
Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area
Yanfang Xia et al. J Neurosci. 2011.
Abstract
The midbrain ventral tegmental area (VTA) projection to the nucleus accumbens (NAc) is implicated in motivation and reinforcement. A significant number of NAc medium spiny neurons (MSNs) project back to the VTA, although the nature of this projection is essentially unknown. For example, do NAc MSNs directly target accumbens-projecting dopamine neurons and do they act via the GABA(A) or GABA(B) receptor? To address these issues, we expressed the light-sensitive channel rhodopsin-2 in the rat NAc and made electrophysiological recordings from VTA neurons ex vivo. We found that the NAc directly targets non-dopaminergic VTA neurons, including some that project back to the NAc. These MSN GABAergic terminals are opioid sensitive and act via GABA(A) receptors.
Figures
Figure 1.
ChR2-expression in the NAc. A, Confocal image of ChR2–tdtomato expression (red) in NAc neurons. Scale bar, 50 ìm. B, Diagram of experimental design: light stimulation (blue) of ChR2 expressing NAc MSN (red). C, Example recording from an MSN showing responses to 1 ms pulses of light at three different intensities. D, MSNs can follow trains of light pulses up to 100 Hz. E, Average probability of firing an action potential (AP) for each stimulus in a train for three different frequencies (n = 6). F, Example recording of a light-evoked IPSC in a neighboring uninfected MSN (current is inward when holding MSN at −75 mV). This IPSC was entirely blocked after the application of picrotoxin (PTX). G, IPSCs evoked in response to a 50 Hz train of light.
Figure 2.
ChR2-expressing MSNs project to the VTA. A, Confocal image of ChR2–tdtomato expression (red) in axon terminals within the VTA near TH+ neurons (green) after microinjection into the NAc. Scale bar, 50 ìm. B, Diagram of experimental design: light stimulates ChR2-expressing NAc MSN terminals (red) while recording from uninfected VTA neurons. C, Example recording from VTA neuron showing responses to two 3 ms pulses of light, 50 ms apart. This IPSC was entirely blocked after application of picrotoxin (PTX). Bottom graph shows time course of pharmacological effect.
Figure 3.
Lack of light-evoked GABAB response in VTA neurons. A, Average of five consecutive traces in an NAc-connected neuron after the GABAA response was blocked with 100 μ
m
picrotoxin and after application of the GABAB receptor antagonist CGP-55845 [(2_S_)-3-[(15)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl)(phenylmethyl)phosphinic acid] shows no response to 100 Hz light stimulation. B, The amplitude of electrically evoked GABAB IPSCs depends on the stimulation frequency. C, The addition of NNC-711 (10 μ
m
) does not reveal a light-evoked GABAB IPSC. D, NNC-711 enhanced electrically evoked GABAB IPSCs. E, Bath application of 20 μ
m
baclofen produced a small outward current in a neuron that received input from the NAc (top) compared with the response of a control TH (+) neuron (bottom). F, Connected neurons (n = 5) showed significantly smaller baclofen responses than TH (+) control neurons (n = 9), which had larger responses to baclofen than identified TH (−) neurons (n = 5). *p < 0.05, **p < 0.01.
Figure 4.
NAc MSNs target VTA non-dopamine neurons. A, Proportion of connected and unconnected neurons that express the _I_h. B, Among _I_h-expressing neurons, there was no difference in the magnitude of the _I_h in connected and unconnected neurons. C, Example of a biocytin-filled TH (−) neuron that responded to light stimulation with an IPSC. Biocytin, Red; TH, green. Inset shows summary of TH immunocytochemistry for connected and unconnected neurons. *p < 0.01.
Figure 5.
NAc MSNs target NAc-projecting VTA neurons. A, Triple-labeled VTA slice showing TH (green), DiI (violet), and ChR2 (red) after microinjection of DiI and ChR2 into the NAc. Scale bar, 20 ìm. B, Diagram of experimental design. Light stimulation (blue) of ChR2-expressing NAc MSN terminals (red) while recording from retrogradely labeled VTA neurons (violet). C, Ten consecutive light-evoked IPSCs from a retrogradely labeled VTA neuron. D, Distribution of action potential durations from connected (blue) and unconnected (red) NAc-projecting neurons. Inset shows average of 10 consecutive action potentials (AP; from example in C). Dashed line indicates where action potential duration was measured.
Figure 6.
NAc projections to the VTA are inhibited by μ-opioids. Bath application of the μ-opioid receptor agonist DAMGO (1 μ
m
) inhibited light-evoked IPSCs arising from the NAc (n = 9). Top traces show average of five consecutive IPSCs from control (left) and in DAMGO (right).
Figure 7.
Circuit diagram of NAc connections within the VTA MSNs of the NAc synapse onto non-dopaminergic neurons in the VTA, including some that project back to the NAc. NAc MSNs do not synapse onto VTA dopamine neurons but may indirectly modulate their activity through local connections within the VTA.
Similar articles
- Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning.
Brown MT, Tan KR, O'Connor EC, Nikonenko I, Muller D, Lüscher C. Brown MT, et al. Nature. 2012 Dec 20;492(7429):452-6. doi: 10.1038/nature11657. Epub 2012 Nov 25. Nature. 2012. PMID: 23178810 - The Projection Targets of Medium Spiny Neurons Govern Cocaine-Evoked Synaptic Plasticity in the Nucleus Accumbens.
Baimel C, McGarry LM, Carter AG. Baimel C, et al. Cell Rep. 2019 Aug 27;28(9):2256-2263.e3. doi: 10.1016/j.celrep.2019.07.074. Cell Rep. 2019. PMID: 31461643 Free PMC article. - Differential expression of long-term potentiation among identified inhibitory inputs to dopamine neurons.
Simmons DV, Petko AK, Paladini CA. Simmons DV, et al. J Neurophysiol. 2017 Oct 1;118(4):1998-2008. doi: 10.1152/jn.00270.2017. Epub 2017 Jul 12. J Neurophysiol. 2017. PMID: 28701538 Free PMC article. - Dopamine-glutamate neuron projections to the nucleus accumbens medial shell and behavioral switching.
Mingote S, Amsellem A, Kempf A, Rayport S, Chuhma N. Mingote S, et al. Neurochem Int. 2019 Oct;129:104482. doi: 10.1016/j.neuint.2019.104482. Epub 2019 Jun 3. Neurochem Int. 2019. PMID: 31170424 Free PMC article. Review. - Opioid-induced structural and functional plasticity of medium-spiny neurons in the nucleus accumbens.
Thompson BL, Oscar-Berman M, Kaplan GB. Thompson BL, et al. Neurosci Biobehav Rev. 2021 Jan;120:417-430. doi: 10.1016/j.neubiorev.2020.10.015. Epub 2020 Nov 2. Neurosci Biobehav Rev. 2021. PMID: 33152423 Free PMC article. Review.
Cited by
- Early Life Stress- and Drug-Induced Histone Modifications Within the Ventral Tegmental Area.
Shepard RD, Nugent FS. Shepard RD, et al. Front Cell Dev Biol. 2020 Sep 30;8:588476. doi: 10.3389/fcell.2020.588476. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33102491 Free PMC article. Review. - Manipulating ΔFOSB in D1-Type Medium Spiny Neurons of the Nucleus Accumbens Reshapes Whole-Brain Functional Connectivity.
Sourty M, Nasseef MT, Champagnol-Di Liberti C, Mondino M, Noblet V, Parise EM, Markovic T, Browne CJ, Darcq E, Nestler EJ, Kieffer BL. Sourty M, et al. Biol Psychiatry. 2024 Feb 1;95(3):266-274. doi: 10.1016/j.biopsych.2023.07.013. Epub 2023 Jul 28. Biol Psychiatry. 2024. PMID: 37517704 Free PMC article. - Nucleus Accumbens Subnuclei Regulate Motivated Behavior via Direct Inhibition and Disinhibition of VTA Dopamine Subpopulations.
Yang H, de Jong JW, Tak Y, Peck J, Bateup HS, Lammel S. Yang H, et al. Neuron. 2018 Jan 17;97(2):434-449.e4. doi: 10.1016/j.neuron.2017.12.022. Epub 2018 Jan 4. Neuron. 2018. PMID: 29307710 Free PMC article. - Neuronal circuits underlying acute morphine action on dopamine neurons.
Jalabert M, Bourdy R, Courtin J, Veinante P, Manzoni OJ, Barrot M, Georges F. Jalabert M, et al. Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16446-50. doi: 10.1073/pnas.1105418108. Epub 2011 Sep 19. Proc Natl Acad Sci U S A. 2011. PMID: 21930931 Free PMC article. - Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges.
Galaj E, Newman AH, Xi ZX. Galaj E, et al. Neurosci Biobehav Rev. 2020 Jul;114:38-52. doi: 10.1016/j.neubiorev.2020.04.024. Epub 2020 May 3. Neurosci Biobehav Rev. 2020. PMID: 32376243 Free PMC article. Review.
References
- Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther. 1993;264:489–495. - PubMed
- Bechara A, Harrington F, Nader K, van der Kooy D. Neurobiology of motivation: double dissociation of two motivational mechanisms mediating opiate reward in drug-naive versus drug-dependent animals. Behav Neurosci. 1992;106:798–807. - PubMed
- Cameron DL, Williams JT. Dopamine D1 receptors facilitate transmitter release. Nature. 1993;366:344–347. - PubMed
- Carr DB, Sesack SR. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse. 2000a;38:114–123. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous